HBM-1007

N/A

Report date: 2023/12/25 16:52:40

Base Information

Drug NameHBM-1007
Drug Alias NameHBM-1007HBM1007R 1007HBM 1007
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of Action5'-nucleotidase inhibitors
Targets5'-nucleotidase
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHarbour Biomed
China Registration ClassN/A

Develop Information

Active CompaniesHarbour Biomed
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A